Surveillance of influenza and other respiratory viruses in the UK: Winter 2017-18

This report describes influenza activity experienced in UK from week 40, 2017 to week 15, 2018 and includes observations and commentary from the childhood vaccination programme and activity of other seasonal and novel respiratory viruses.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news

Related Links:

The EMA CHMP has recommended granting marketing authorization for Flucelvax Tetra (Seqirus Netherlands BV), a quadrivalent cell-based influenza vaccine.International Approvals
Source: Medscape Nurses Headlines - Category: Nursing Tags: Infectious Diseases News Alert Source Type: news
This study aims to identify the determinants of, and the reasons for, non-vaccination. DATA AND METHODS: Data from the 2013/2014 Canadian Community Health Survey (CCHS) were used. Respondents were divided into three groups: adults aged 18 to 64 years with a chronic medical condition (CMC), adults in the same age group with no CMC, and adults aged 65 years and older. Logistic regressions were used to measure the association between sociodemographic factors and non-vaccination. RESULTS: Among adults aged 65 years and older, the proportion of non-vaccinated persons was 36.2%. This proportion was higher among adults ag...
Source: Health Reports - Category: International Medicine & Public Health Tags: Health Rep Source Type: research
The highly pathogenic avian influenza virus H5N1 is a major threat to global public health and therefore a high-priority target of current vaccine development. The receptor-binding site (RBS) on the globular head of hemagglutinin (HA) in the viral envelope is one of the major target sites for antibody recognition against H5N1 and other influenza viruses. Here, we report the identification and characterization of a pair of human RBS–specific antibodies, designated FLD21.140 and AVFluIgG03, that are mutually complementary in their neutralizing activities against a diverse panel of H5N1 viruses. Crystallographic analysi...
Source: Journal of Biological Chemistry - Category: Chemistry Authors: Tags: Microbiology Source Type: research
What to do about in-laws who don ’ t do vaccines.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Customs, Etiquette and Manners Vaccination and Immunization Influenza Children and Childhood Source Type: news
THURSDAY, Oct. 18, 2018 -- Many pregnant women are not getting recommended vaccinations, with less than half of those pregnant during the peak influenza vaccination period in 2017 to 2018 reporting being vaccinated before or during their pregnancy,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
(Mary Ann Liebert, Inc./Genetic Engineering News) Researchers developed a novel DNA influenza vaccine based on four micro-consensus antigenic regions selected to represent the diversity of seasonal H3N2 viruses across decades.
Source: EurekAlert! - Biology - Category: Biology Source Type: news
WEDNESDAY, Oct. 16, 2018 -- Administering influenza vaccines through pharmacies in addition to traditional locations can increase vaccination coverage in the event of an epidemic, according to a study published online Oct. 16 in Vaccine. Sarah M....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
Source: RxList - New and Updated Drug Monographs - Category: Drugs & Pharmacology Source Type: news
Source: RxList - New and Updated Drug Monographs - Category: Drugs & Pharmacology Source Type: news
Antigens on the surface of virus particles are displayed in a regular, repetitive pattern which facilitates B cell activation. Presenting trimeric antigens on engineered particles that mimic the geometric patterns observed for native viral proteins can lead to an improved host antibody response.Self-assembling globular ferritin nanoparticles have previously been used to display multiple copies of a co-assembled trimeric antigen to the immune system. However, prior ferritin nanoparticle technologies only permit a random co-assembly of diverse trimeric antigens, and therefore cannot guarantee the pattern and ratio of diverse...
Source: NIH OTT Licensing Opportunities - Category: Research Authors: Source Type: research
More News: Health | Influenza | Influenza Vaccine | Respiratory Medicine | Vaccines